Clinical trials
Terminated Astrocytoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
99 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 4 |
| 2002 | 3 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 4 |
| 2006 | 4 |
| 2007 | 3 |
| 2008 | 8 |
| 2009 | 2 |
| 2010 | 9 |
| 2011 | 7 |
| 2012 | 5 |
| 2013 | 6 |
| 2014 | 5 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 5 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 99 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 12 |
| Pediatric Brain Tumor Consortium | 9 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 6 |
| Wake Forest University Health Sciences | 4 |
| Burzynski Research Institute | 3 |
| M.D. Anderson Cancer Center | 3 |
| Tocagen Inc. | 3 |
| Case Comprehensive Cancer Center | 2 |
| Day One Biopharmaceuticals, Inc. | 2 |
| Masonic Cancer Center, University of Minnesota | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Astrocytoma | 99 |
| Glioblastoma | 66 |
| Oligodendroglioma | 59 |
| Glioma | 54 |
| Brain Neoplasms | 36 |
| Gliosarcoma | 30 |
| Central Nervous System Neoplasms | 21 |
| Ependymoma | 19 |
| Medulloblastoma | 15 |
| Optic Nerve Glioma | 11 |
Trials
Showing 26 to 50 of 99. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.